An International Study on Pediatric Patients With Rare Tumors.

NCT07072143 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6250

Last updated 2025-07-18

No results posted yet for this study

Summary

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Conditions

  • Paraganglioma/ Phaeochromocytoma
  • Melanoma and Other Malignant Neoplasms of Skin
  • Gastrointestinal Stromal Tumor (GIST)
  • Adrenocortical Tumor
  • Pancreatic Tumors
  • Esthesioneuroblastoma, Olfactory
  • Mesothelioma
  • Nasopharyngeal Carcinoma (NPC)
  • NUT Carcinoma
  • Pleuropulmonary Blastoma
  • Salivary Gland Tumors
  • Thymic Tumors
  • Thyroid Carcinoma
  • Appendiceal Cancers

Sponsors & Collaborators

  • St. Anna Children's Hospital, Vienna

    collaborator UNKNOWN
  • Children's Hospital Zagreb

    collaborator OTHER
  • Centre Hospitalier Universitaire de La Réunion, FRANCE

    collaborator UNKNOWN
  • Klinikum Dortmund

    collaborator UNKNOWN
  • University Children's Hospital Tuebingen

    collaborator OTHER
  • Hellenic Oncology Research Group

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER
  • Kaplan Medical Center, Rehovot, Israel

    collaborator UNKNOWN
  • Vilnius University hospital Santaros klinikos, Vilnius, Lithuania

    collaborator UNKNOWN
  • University of Skopje

    collaborator OTHER
  • Gdansk Medical University (Poland)

    collaborator UNKNOWN
  • Centro Hospitalar do Porto

    collaborator OTHER
  • Bucharest Emergency Hospital

    collaborator OTHER
  • Institute for Oncology and Radiology Serbia, Belgrade

    collaborator UNKNOWN
  • University Hospital Bratislava

    collaborator OTHER
  • University Medical Centre Ljubljana

    collaborator OTHER
  • University of Bilbao

    collaborator UNKNOWN
  • Göteborg University

    collaborator OTHER
  • University Hospital, Paris

    collaborator OTHER
  • Azienda Ospedaliera di Padova

    lead OTHER

Principal Investigators

  • Gianni Bisogno, MD · Azienda Ospedale Università Padova - Italy

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-25
Primary Completion
2049-01-06
Completion
2049-06-06

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07072143 on ClinicalTrials.gov